Ruohui Chen

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 4

Top Topics

Randomized Controlled Trial

Squamous Cell Carcinoma

African American

Top Venues

JMIR mHealth and uHealth

This page only lists publications with an associated author ORCID identifier.

Publications

Reem Karmali, Carlos Galvez, Mehdi Hamadani, Leo I Gordon, Jane N Winter, Shuo Ma, Valerie Nelson, Timothy S Fenske, Nirav N Shah, Deepa Jagadeesh, Andreas K Klein, Irene Helenowski, Ruohui Chen, Xinlei Mi, Adam Petrich, Andrew M Evens, Barbara Pro
A Phase I-II Trial of DA-EPOCH-R Plus Ixazomib for MYC-Aberrant Lymphoid Malignancies: The DACIPHOR Regimen. Blood advances (2024)
Reem Karmali, Carlos Galvez, Mehdi Hamadani, Leo I Gordon, Jane Winter, Shuo Ma, Valerie Nelson, Timothy S Fenske, Nirav N Shah, Deepa Jagadeesh, Andreas Klein, Irene Helenowski, Ruohui Chen, Xinlei Mi, Adam Petrich, Andrew M Evens, Barbara Pro
A phase 1-2 trial of DA-EPOCH-R plus ixazomib for MYC-aberrant lymphoid malignancies: the DACIPHOR regimen. Blood advances 8 (7) (2024)
Reem Karmali, Carlos Galvez, Mehdi Hamadani, Leo I Gordon, Jane Winter, Shuo Ma, Valerie Nelson, Timothy S Fenske, Nirav N Shah, Deepa Jagadeesh, Andreas Klein, Irene Helenowski, Ruohui Chen, Xinlei Mi, Adam Petrich, Andrew M Evens, Barbara Pro
A phase 1-2 trial of DA-EPOCH-R plus ixazomib for MYC-aberrant lymphoid malignancies: the DACIPHOR regimen. Blood advances 8 (7) (2024)
Sheri J Hartman, Ruohui Chen, Rowena M Tam, Hari K Narayan, Loki Natarajan, Lin Liu
Fitbit Use and Activity Levels From Intervention to 2 Years After: Secondary Analysis of a Randomized Controlled Trial. JMIR mHealth and uHealth 10 (6) (2022)